More on FBLG

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (5.0 Score)

Upcoming Events

- Earnings (11/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

FibroBiologics (NQ:FBLG)
Delayed: 1.87 +0.15 (8.72%)
Prev. Close $1.72  
Open$1.73 
52 Wk High$ 
52 Wk Low$ 
Day High$1.98 
Day Low$1.72 
P/E N/A  
EPS$ 
Volume802,697 

Friends, Peers and Foes (?): CGTX, COCP, PDSB, TNXP, 6XB2 (more...)

Aug 27, 2026 08:31 AM FibroBiologics ships third CYWC628 batch to Australia for DFU trial
Aug 27, 2026 08:30 AM FibroBiologics Releases Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial
Aug 26, 2026 08:30 AM FibroBiologics regains Nasdaq compliance for bid price rule
Aug 26, 2026 08:30 AM FibroBiologics Regains Compliance with Nasdaq Trading Rules
Aug 24, 2026 08:48 AM Form 8-K FibroBiologics, Inc. For: Aug 20
Aug 24, 2026 08:31 AM FibroBiologics adds sports agent Leigh Steinberg to its board
Aug 24, 2026 08:30 AM FibroBiologics Appoints Leigh Steinberg to Board of Directors
Aug 20, 2026 08:31 AM FibroBiologics wins Australian patent for cannabidiol and cell therapy combo
Aug 20, 2026 08:30 AM FibroBiologics Announces Australian Patent Accepted for Cannabidiol Adjuvant Therapy for the Treatment of Degenerative Disc Disease
Aug 18, 2026 08:31 AM FibroBiologics reports cartilage repair in animal study of joint therapy
View All Articles

Entities mentioned with FBLG

View All Entities